NCT06899516

Brief Summary

Context and problem In France, 61% of households own a pet, highlighting the significant role pets play in the daily lives. Patients diagnosed with brain tumors face specific challenges that may affect their ability to care their pets, including:

  • Progressive neurological deficits (cognitive and/or motor), limiting their autonomy,
  • A life-threatening prognosis. In this context, the well-being of pets when their owner's health deteriorates becomes a critical concern. Indeed:
  • Social isolation and the progressive loss of physical and cognitive abilities complicate pet care, particularly during prolonged hospitalizations or in the event of death,
  • The lack of appropriate facilities and care solutions causes stress for pets, who are often unprepared for such transitions, and adds to the emotional burden on patients. Why focus on patients with brain tumors?
  • These patients have specific needs due to the rapid progression of their condition,
  • A local study showed that 12% of patients with gliomas live alone, a significantly higher rate than in other cancer types. Patients who live alone are particularly exposed to issues related to their pet's future,
  • Given the high morbidity and mortality associated with brain tumors, proactive planning for pet care is particularly urgent.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 20, 2025

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

March 21, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 28, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

April 3, 2025

Status Verified

March 1, 2025

Enrollment Period

12 months

First QC Date

March 21, 2025

Last Update Submit

April 1, 2025

Conditions

Brain (Nervous System) Cancers

Keywords

Brain tumorsGlioma patientsPet careEmotional burden

Outcome Measures

Primary Outcomes (1)

  • LAPS scale

    The Lexington Pet Attachment Scale (LAPS) measures the percentage of patients who are concerned about their pets. Values range from zero to one hundred, with higher scores indicating greater concern for pets.

    Day 1

Secondary Outcomes (1)

  • Questionnaire

    Day 1

Study Arms (1)

Pet-owning brain tumour patients

To assess the concerns and needs of patients with brain tumors regarding their pets, in order to plan for the pets' future when their owners are hospitalized, unable to care for them due to their condition, or in the event of their death.

Other: The Lexington Attachment to Pets Scale (LAPS; Johnson, Garrity, & Stallones, 1992)

Interventions

The Lexington Attachment to Pets Scale (LAPS; Johnson, Garrity, & Stallones, 1992)OTHER

The LAPS is a established tool for measuring the emotional bond between humans and their animal companions. Animal attachment is assessed according to three factors: the bond between owners and their dogs or cats, the closeness of the human-animal relationship, and the importance of the animal in the owner's life (Johnson et al., 1992). Higher scores indicate greater attachment.

Pet-owning brain tumour patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with a brain tumor who have one or more pets will be included.

You may qualify if:

  • Patients diagnosed with a brain tumor.
  • Patients who own at least one pet.

You may not qualify if:

  • Patients who decline to participate in the study.
  • Patients unable to complete the questionnaire.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Saint Etienne

Saint-Etienne, 42000, France

RECRUITING

MeSH Terms

Conditions

Neurologic ManifestationsNeoplasmsBrain Neoplasms

Interventions

Laparoscopy

Condition Hierarchy (Ancestors)

Nervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCentral Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteBrain DiseasesCentral Nervous System Diseases

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Carole Ramirez, Md

    CHU de SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Carole Ramirez, Md

CONTACT

(0)477829326carole.ramirez@chu-st-etienne.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2025

First Posted

March 28, 2025

Study Start

March 20, 2025

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

April 3, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)